Drynaria fortunei J. Sm. promotes osteoblast maturation by inducing differentiation-related gene expression and protecting against oxidative stress-induced apoptotic insults

Journal of Ethnopharmacology

Volumn 131, Issue 1, 2010, Pages 70-77

  Hung, Tai Yuan ^a,b   Chen, Ta Liang ^c   Liao, Mei Hsiu ^b   Ho, Wei Pin ^b   Liu, Der Zen ^b   Chuang, Wu Chang ^d   Chen, Ruei Ming ^b  

^a YUAN'S GENERAL HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d Brion Research Institute of Taiwan   (Taiwan)

Author keywords

Anti apoptosis; Drynaria fortunei J. Sm.; Gene expression; Osteoblast maturation

Indexed keywords

ALKALINE PHOSPHATASE; BETA ACTIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 6; COLLAGEN TYPE 1; DRYNARIA FORTUNEI EXTRACT; MESSENGER RNA; OSTEOCALCIN; OSTEOPONTIN; PLANT EXTRACT; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; BONE MINERALIZATION; CALVARIA; CELL MATURATION; CELL PROLIFERATION; CELL VIABILITY; CHINESE HERB; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG MECHANISM; DRUG SCREENING; DRYNARIA FORTUNEI; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; MEDICINAL PLANT; NITROSATIVE STRESS; NONHUMAN; OSTEOBLAST; OXIDATIVE STRESS; QUANTITATIVE ANALYSIS; RAT; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; CELL DIFFERENTIATION; CELLS, CULTURED; DRUGS, CHINESE HERBAL; GENE EXPRESSION REGULATION, DEVELOPMENTAL; OSTEOBLASTS; OSTEOGENESIS; OXIDATIVE STRESS; POLYPODIACEAE; RATS; RATS, WISTAR;

DRYNARIA FORTUNEI; RATTUS;

EID: 77955311368     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2010.05.063     Document Type: Article

References (29)

1. Aubin J.E. Bone stem cells. Journal of Cellular Biochemistry 1998, 30-31:73-82.
2. Chang C.C., Liao Y.S., Lin Y.L., Chen R.M. Nitric oxide protects osteoblasts from oxidative stress-induced apoptotic insults via a mitochondria-dependent mechanism. Journal of Orthopaedic Research 2006, 24:1917-1925.
3. Chen R.M., Chen T.L., Chiu W.T., Chang C.C. Molecular mechanism of nitric oxide-induced osteoblast apoptosis. Journal of Orthopaedic Research 2005, 23:462-468.
4. Cooper L.F., Yliheikkila P.K., Felton D.A., Whitson S.W. Spatiotemporal assessment of fetal bovine osteoblast culture differentiation indicates a role for BSP in promoting differentiation. Journal of Bone and Mineral Research 1998, 13:620-632.
5. Ducy P., Schinke T., Karsenty G. The osteoblast: a sophisticated fibroblast under central surveillance. Science 2000, 289:1501-1504.
6. Giustina A., Mazziotti G., Canalis E. Growth hormone, insulin-like growth factors, and the skeleton. Endocrine Reviews 2008, 29:535-559.
7. Grasser W.A., Orlic I., Borovecki F., Riccardi K.A., Simic P., Vukicevic S., Paralkar V.M. BMP-6 exerts its osteoinductive effect through activation of IGF-I and EGF pathways. International Orthopaedics 2007, 31:759-765.
8. Ho W.P., Chan W.P., Hsieh M.S., Chen R.M. Runx2-mediated Bcl-2 gene expression contributes to nitric oxide protection against oxidative stress-induced osteoblast apoptosis. Journal of Cellular Biochemistry 2009, 108:1084-1093.
9. Jia D., Heersche J.N. Insulin-like growth factor-1 and -2 stimulate osteoprogenitor proliferation and differentiation and adipocyte formation in cell populations derived from adult rat bone. Bone 2000, 27:785-794.
10. Jun J.H., Lee S.H., Kwak H.B., Lee Z.H., Seo S.B., Woo K.M., Ryoo H.M., Kim G.S., Baek J.H. N-acetylcysteine stimulates osteoblastic differentiation of mouse calvarial cells. Journal of Cellular Biochemistry 2008, 103:1246-1255.
11. Koch H., Jadlowiec J.A., Campbell P.G. Insulin-like growth factor-I induces early osteoblast gene expression in human mesenchymal stem cells. Stem Cells and Development 2005, 14:621-631.
12. Kugimiya F., Kawaguchi H., Kamekura S., Chikuda H., Ohba S., Yano F., Ogata N., Katagiri T., Harada Y., Azuma Y., Nakamura K., Chung U.I. Involvement of endogenous bone morphogenetic protein (BMP) 2 and BMP6 in bone formation. The Journal of Biological Chemistry 2005, 280:35704-35712.
13. Lee K.H., Choi E.M. Myricetin, a naturally occurring flavonoid, prevents 2-deoxy-D-ribose induced dysfunction and oxidative damage in osteoblastic MC3T3-E1 cells. The European Journal of Pharmacology 2008, 591:1-6.
14. Lee S.T., Wu T.T., Yu P.Y., Chen R.M. Apoptotic insults to human HepG2 cells induced by S-(+)-ketamine occurs through activation of a Bax-mitochondria-caspase protease pathway. British Journal of Anaesthesia 2009, 102:80-89.
15. Liu H.C., Chen R.M., Jian W.C., Lin Y.L. Cytotoxic and antioxidant effects of the water extract of traditional Chinese herb Gusuibu (Drynaria fortunei) on rat osteoblasts. Journal of the Formosan Medical Association 2001, 100:383-388.
16. Long M., Qiu D., Li F., Johnson F., Luft B. Flavonoid of Drynaria fortunei protects against acute renal failure. Phytotherapy Research 2005, 19:422-427.
17. Reseland J.E., Syversen U., Bakke I., Qvigstad G., Eide L.G., Hjertner O., Gordeladze J.O., Drevon C.A. Leptin is expressed in and secreted from primary cultures of human osteoblasts and promotes bone mineralization. Journal of Bone and Mineral Research 2001, 16:1426-1433.
18. Seeman E., Delmas P.D. Bone quality-the material and structural basis of bone strength and fragility. The New England Journal of Medicine 2006, 354:2250-2261.
19. Shapiro F. Bone development and its relation to fracture repair. The role of mesenchymal osteoblasts and surface osteoblasts. European Cells and Materials 2008, 15:53-76.
20. Shouhed D., Kha H.T., Richardson J.A., Amantea C.M., Hahn T.J., Parhami F. Osteogenic oxysterols inhibit the adverse effects of oxidative stress on osteogenic differentiation of marrow stromal cells. Journal of Cellular Biochemistry 2005, 95:1276-1283.
21. Stein G.S., Lian J.B., Stein J.L., Van Wijnen A.J., Montecino M. Transcriptional control of osteoblast growth and differentiation. Physiological Reviews 1996, 76:593-624.
22. Trzeciakiewicz A., Habauzit V., Mercier S., Lebecque P., Davicco M.J., Coxam V., Demigne C., Horcajada M.N. Hesperetin stimulates differentiation of primary rat osteoblasts involving the BMP signalling pathway. The Journal of Nutritional Biochemistry 2010, 21:424-431.
23. van Leeuwen J.P., van Driel M., van den Bemd G.J., Pols H.A. Vitamin D control of osteoblast function and bone extracellular matrix mineralization. Critical Reviews in Eukaryotic Gene Expression 2001, 11:199-226.
24. Vandenput L., Ohlsson C. Estrogens as regulators of bone health in men. Nature Reviews Endocrinology 2009, 5:437-443.
25. Wang X.L., Wang N.L., Zhang Y., Gao H., Pang W.Y., Wong M.S., Zhang G., Qin L., Yao X.S. Effects of eleven flavonoids from the osteoprotective fraction of Drynaria fortunei (KUNZE) J. SM. on osteoblastic proliferation using an osteoblast-like cell line. Chemical and Pharmaceutical Bulletin 2008, 56:46-51.
26. Wong R.W., Rabie A.B. Systemic effect of crude extract from rhizome of Drynaria fortunei on bone formation in mice. Phytotherapy Research 2006, 20:313-315.
27. Wu X., Shi W., Cao X. Multiplicity of BMP signaling in skeletal development. The Annals of the New York Academy of Sciences 2007, 1116:29-49.
28. Yamachika E., Tsujigiwa H., Shirasu N., Ueno T., Sakata Y., Fukunaga J., Mizukawa N., Yamada M., Sugahara T. Immobilized recombinant human bone morphogenetic protein-2 enhances the phosphorylation of receptor-activated Smads. Journal of Biomedical Materials Research 2009, 88:599-607.
29. Yeler H., Tahtabas F., Candan F. Investigation of oxidative stress during fracture healing in the rats. Cell Biochemistry and Function 2005, 23:137-139.